Headline
The latest stories from AHA Today.
The Food and Drug Administration released a final rule Sept. 18 that rescinds one from 2024 that applied medical device rules to laboratory-developed tests. The final rule is in response to a March 31 federal district court decision that also vacated the FDA’s 2024 final rule.
The Senate Sept. 18 passed the AHA-supported SUPPORT Act (H.R. 2483) by a voice vote, advancing the bill to President Trump to sign into law.
Microsoft Sept. 16 announced it had disrupted a growing phishing service that had targeted at least 20 U.S. health care organizations and seized 338 websites associated with cyber threat group RaccoonO365.
The Joint Commission and the Coalition for Health AI released guidance Sept. 17 on the responsible use of artificial intelligence in health care, the first installment from their partnership that launched in June.
The National Institutes of Health Sept. 16 announced it has launched a consortium to help reduce preventable stillbirths across the U.S.
The Healthcare Association of New York State Sept. 16 announced Bea Grause, R.N., its president and CEO, will retire in summer 2026.
The AHA submitted a statement Sept. 17 for a House Ways and Means Committee markup session on a series of health care and other bills.
A bipartisan House letter by Reps. Dan Crenshaw, R-Texas, Yvette D. Clarke, D-N.Y., Gus M. Bilirakis, R-Fla., and Diana DeGette, D-Colo., urged House leadership to prevent reductions to the Medicaid Disproportionate Share Hospital program that are scheduled to take effect Oct. 1.
The Food and Drug Administration recently disclosed dozens of warning letters sent to drug companies that accuse them of using misleading or deceptive advertising.
A blog by Julia Resnik, AHA senior director of health outcomes and care transformation, describes a new project with the Commonwealth Fund that will explore how rural hospitals leverage assets in their hospital and community to maintain or expand access to care for pregnant women.